Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Immunology/Inflammation related
    (1)
  • Integrin
    (1)
Filter
Search Result
Results for "

anatumomab

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    2
    TargetMol | Inhibitory_Antibodies
Blinatumomab
MT-103, MT103, bscCD19xCD3, AMG-10, AMG10
T78317853426-35-4
Blinatumomab (AMG-10,MT-103) is a CD19 CD3 bispecific B-cell and T-cell binding antibody that directs T-cells to attack cancer cells by binding to both CD3 on T-cells and CD19 on cancer cells, and is used in acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
  • Inquiry Price
7-10 days
Size
QTY
Anatumomab mafenatox
ABR-214936
T831211370261-50-9
Anatumomab mafenatox (ABR-214936), a 73 KDa recombinant protein, targets the tumor-associated antigen 5T4 commonly expressed in malignancies. It is a conjugate comprising a modified form of SEA linked to a murine Fab. The primary adverse effects of Anatumomab mafenatox include fever, hypotension, pain, nausea, and drowsiness [1].
  • Inquiry Price
Size
QTY